| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $1.93 (Beat by $0.16) |
| EPS GAAP Actual | $1.93 (Beat by $0.16) |
| Revenue Actual | $9.59319B |
| Revenue Surprise | Beat by $9593.19M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.5449 |
| EPS GAAP Estimate | $1.5449 |
| Revenue Estimate | $10.875855759B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 15.46922 | 13.14 | 14.89334 | 16.71949 | 1 |
| Dec 2029 | 12.03807 | 16.89 | 11.70128 | 12.29756 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.57 | 1.57 | 9.59319B | 2.25% | 9593.19M |
| FQ3 2025 (Sep 2025) | 1.72 | 1.72 | 9.076B | 6.68% | 9076M |
| FQ2 2025 (Jun 2025) | 1.5 | 1.5 | 9.027B | 8.19% | 9027M |
| FQ1 2025 (Mar 2025) | 1.52 | 1.52 | 9.013B | 10.78% | 9013M |
| FQ4 2024 (Dec 2024) | 2.75 | 2.75 | 9.377B | 9.7% | 9377M |
| FQ3 2024 (Sep 2024) | 1.38 | 1.38 | 8.47B | 8.57% | 8470M |
| FQ2 2024 (Jun 2024) | 0.76 | 0.76 | 8.288B | 8.84% | 8288M |
| FQ1 2024 (Mar 2024) | -0.71 | -0.71 | 8.041B | 7.46% | 8041M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.5449
Consensus Revenue Estimates
10.875855759B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.6421 | -- | 2.57243 | 2.76727 | 1 |
| FQ3 2027 (Sep 2027) | 2.42596 | -- | 2.36199 | 2.54089 | 1 |
| FQ2 2027 (Jun 2027) | 2.24878 | -- | 2.18948 | 2.35532 | 1 |
| FQ1 2027 (Mar 2027) | 2.21751 | -- | 2.15904 | 2.32257 | 1 |
| FQ4 2026 (Dec 2026) | 2.17831 | 27.93 | 2.12087 | 2.28151 | 1 |
| FQ3 2026 (Sep 2026) | 2.00997 | 14.43 | 1.95697 | 2.1052 | 1 |
| FQ2 2026 (Jun 2026) | 1.94607 | 22.92 | 1.89476 | 2.03827 | 1 |
| FQ1 2026 (Mar 2026) | 1.5449 | 1.61 | 1.52238 | 1.56555 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 14.22B | -- | 13.93B | 14.74B | 3 |
| FQ3 2027 (Sep 2027) | 13.37B | -- | 13.1B | 13.86B | 3 |
| FQ2 2027 (Jun 2027) | 13.04B | -- | 12.78B | 13.52B | 3 |
| FQ1 2027 (Mar 2027) | 12.73B | -- | 12.47B | 13.19B | 3 |
| FQ4 2026 (Dec 2026) | 12.63B | 24.05 | 12.37B | 13.09B | 3 |
| FQ3 2026 (Sep 2026) | 11.88B | 23.61 | 11.64B | 12.31B | 4 |
| FQ2 2026 (Jun 2026) | 11.59B | 22.11 | 11.35B | 12.01B | 5 |
| FQ1 2026 (Mar 2026) | 10.88B | 17.13 | 10.75B | 10.99B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.57 | 1.57 | 100% | |
| FQ3 2025 (Sep 2025) | 1.72 | 1.72 | 100% | |
| FQ2 2025 (Jun 2025) | 1.5 | 1.5 | 100% | |
| FQ1 2025 (Mar 2025) | 1.52 | 1.52 | 100% | |
| FQ4 2024 (Dec 2024) | 2.75 | 2.75 | 100% | |
| FQ3 2024 (Sep 2024) | 1.38 | 1.38 | 100% | |
| FQ2 2024 (Jun 2024) | 0.76 | 0.76 | 100% | |
| FQ1 2024 (Mar 2024) | -0.71 | -0.71 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $9.59B | $9593.19M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $9.08B | $9076M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $9.03B | $9027M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $9.01B | $9013M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $9.38B | $9377M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $8.47B | $8470M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $8.29B | $8288M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $8.04B | $8041M | 100% |